Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Comparing radial extracorporeal shockwave therapy and corticosteroid injection in the treatment of piriformis syndrome: A randomized clinical trial (2023) |
Auteurs : | Tannaz Ahadi ; Arastoo Yousefi ; Simin Sajadi ; Naseh Yousefi ; Arash Babaei-Ghazani |
Type de document : | Article |
Dans : | Journal of Bodywork and Movement Therapies (Vol. 33, Janvier 2023) |
Article en page(s) : | p. 182-188 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Corticostérone ; Mesure de la douleur ; Syndrome du muscle piriforme ; Traitement par ondes de choc extracorporelles |
Résumé : | Objective This study was designed to compare the effects of shockwave therapy and corticosteroid injection in the treatment of piriformis syndrome. Methods and materials In this randomized clinical trial, thirty-five patients with piriformis syndrome were randomly divided into two groups of 18 in the shockwave group and 17 in the corticosteroid group. The Shockwave group underwent three sessions of shockwave therapy per week (2000 pulses per session with 5Hz frequency and pressure equal to 4 Bar) and the corticosteroid group underwent an injection of 40 mg methylprednisolone with 1 mL of 1% lidocaine under ultrasound guidance. All patients were assessed by SF-36 questionnaire and visual analogue scale (VAS). The SF-36 questionnaire was used to evaluate the quality of life before and 4 weeks after the intervention. VAS scale was used to evaluate pain before the intervention, and 1, 4, 8, and 12 weeks after the intervention. Results The baseline characteristics of the two groups were not significantly different. At the end of the study, both groups had a significant improvement in pain and quality of life compared to before the intervention. However, according to the VAS, in the shockwave group improvement was seen in the first follow-up while not seen in the corticosteroid group (P-value |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1360859222001292 |